These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 22370688)

  • 1. von Willebrand factor, shear stress, and ADAMTS13 in hemostasis and thrombosis.
    Tsai HM
    ASAIO J; 2012; 58(2):163-9. PubMed ID: 22370688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand factor: another janus-faced hemostasis protein.
    Franchini M; Mannucci PM
    Semin Thromb Hemost; 2008 Oct; 34(7):663-9. PubMed ID: 19085767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shear stress and von Willebrand factor in health and disease.
    Tsai HM
    Semin Thromb Hemost; 2003 Oct; 29(5):479-88. PubMed ID: 14631548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura.
    Tsai HM
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):388-96. PubMed ID: 12615692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor, von Willebrand factor-cleaving protease, and shear stress.
    Perutelli P; Molinari AC
    Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):305-10. PubMed ID: 17979694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Von Willebrand factor and ADAMTS13 balancing primary haemostasis].
    Schneppenheim R; Budde U
    Hamostaseologie; 2011 Nov; 31(4):275-80. PubMed ID: 21792464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices.
    Rauch A; Legendre P; Christophe OD; Goudemand J; van Belle E; Vincentelli A; Denis CV; Susen S; Lenting PJ
    Thromb Haemost; 2014 Nov; 112(5):1014-23. PubMed ID: 25030452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of fluid shear stress in regulating VWF structure, function and related blood disorders.
    Gogia S; Neelamegham S
    Biorheology; 2015; 52(5-6):319-35. PubMed ID: 26600266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS13 and microvascular thrombosis.
    Tsai HM
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):813-25. PubMed ID: 17173498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential therapeutic benefit of targeting ADAMTS13 activity.
    Eerenberg ES; Levi M
    Semin Thromb Hemost; 2014 Feb; 40(1):28-33. PubMed ID: 24338607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis.
    Sonneveld MA; de Maat MP; Leebeek FW
    Blood Rev; 2014 Jul; 28(4):167-78. PubMed ID: 24825749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis and von Willebrand Factor.
    Shahidi M
    Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor.
    Zhang X; Halvorsen K; Zhang CZ; Wong WP; Springer TA
    Science; 2009 Jun; 324(5932):1330-4. PubMed ID: 19498171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Zhou Z; Nguyen TC; Guchhait P; Dong JF
    Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into von Willebrand factor proteolysis: clinical implications.
    Bowen DJ; Collins PW
    Br J Haematol; 2006 Jun; 133(5):457-67. PubMed ID: 16681634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13.
    Chapman K; Seldon M; Richards R
    Semin Thromb Hemost; 2012 Feb; 38(1):47-54. PubMed ID: 22314603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.
    Zheng XL
    Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.